Sunil Healthcare Limited (BOM:537253)
70.00
-1.50 (-2.10%)
At close: Aug 21, 2026
Sunil Healthcare Revenue
Sunil Healthcare had revenue of 192.14M INR in the quarter ending June 30, 2026, a decrease of -15.14%. This brings the company's revenue in the last twelve months to 834.33M, down -1.34% year-over-year. In the fiscal year ending March 31, 2026, Sunil Healthcare had annual revenue of 877.19M with 5.15% growth.
Revenue (ttm)
834.33M
Revenue Growth
-1.34%
P/S Ratio
0.85
Revenue / Employee
5.22M
Employees
161
Market Cap
717.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 877.19M | 42.98M | 5.15% |
| Mar 31, 2025 | 834.21M | -67.71M | -7.51% |
| Mar 31, 2024 | 901.92M | -202.99M | -18.37% |
| Mar 31, 2023 | 1.10B | -86.73M | -7.28% |
| Mar 31, 2022 | 1.19B | 285.44M | 31.50% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dynemic Products | 3.71B |
| Cochin Minerals and Rutile | 3.42B |
| Natural Capsules | 1.93B |
| Dai-ichi Karkaria | 1.81B |
| India Gelatine & Chemicals | 1.76B |
| Ambica Agarbathies Aroma & Industries | 1.36B |
| Biopol Chemicals | 813.72M |
| Saboo Sodium Chloro | 639.36M |